Fortitude Family Office’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Fortitude Family Office's ATRC Position: Q1 2026 in Review
Fortitude Family Office sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 37 shares — an estimated $1.46K sold.
Fortitude Family Office first reported a position in ATRC in Q2 2025 and held it in 3 quarters. The position peaked at $1.46K in Q4 2025. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- Fortitude Family Office reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
- Fortitude Family Office sold 37 AtriCure shares in Q1 2026, an estimated $1.46K.
- Fortitude Family Office first reported a position in AtriCure in Q2 2025 and held it in 3 quarters.
- Fortitude Family Office's AtriCure position peaked at $1.46K in Q4 2025.
- 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.